JP2003026560A - Activated oxygen-eliminating agent, skin cosmetic material for preventing aging, and method for stabilizing activated oxygen-eliminating activity - Google Patents
Activated oxygen-eliminating agent, skin cosmetic material for preventing aging, and method for stabilizing activated oxygen-eliminating activityInfo
- Publication number
- JP2003026560A JP2003026560A JP2001211889A JP2001211889A JP2003026560A JP 2003026560 A JP2003026560 A JP 2003026560A JP 2001211889 A JP2001211889 A JP 2001211889A JP 2001211889 A JP2001211889 A JP 2001211889A JP 2003026560 A JP2003026560 A JP 2003026560A
- Authority
- JP
- Japan
- Prior art keywords
- active oxygen
- plant extract
- oil
- tannins
- activated oxygen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 25
- 238000000034 method Methods 0.000 title claims description 7
- 239000003795 chemical substances by application Substances 0.000 title abstract description 15
- 230000000694 effects Effects 0.000 title abstract description 7
- 239000000463 material Substances 0.000 title abstract 3
- 230000032683 aging Effects 0.000 title description 2
- 230000000087 stabilizing effect Effects 0.000 title 1
- 239000000419 plant extract Substances 0.000 claims abstract description 30
- 229930003935 flavonoid Natural products 0.000 claims abstract description 16
- 150000002215 flavonoids Chemical class 0.000 claims abstract description 16
- 235000017173 flavonoids Nutrition 0.000 claims abstract description 16
- 229920001864 tannin Polymers 0.000 claims abstract description 16
- 235000018553 tannin Nutrition 0.000 claims abstract description 16
- 239000001648 tannin Substances 0.000 claims abstract description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 6
- -1 octyl paramethoxycinnamate Chemical compound 0.000 claims description 58
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 24
- 239000001301 oxygen Substances 0.000 claims description 24
- 229910052760 oxygen Inorganic materials 0.000 claims description 24
- 229940123973 Oxygen scavenger Drugs 0.000 claims description 18
- 239000006097 ultraviolet radiation absorber Substances 0.000 claims description 17
- 230000003712 anti-aging effect Effects 0.000 claims description 9
- 239000000284 extract Substances 0.000 claims description 9
- 235000006468 Thea sinensis Nutrition 0.000 claims description 8
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 7
- 240000006891 Artemisia vulgaris Species 0.000 claims description 7
- 244000269722 Thea sinensis Species 0.000 claims description 7
- 244000144730 Amygdalus persica Species 0.000 claims description 5
- 235000005206 Hibiscus Nutrition 0.000 claims description 5
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 claims description 5
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 5
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims description 5
- 244000223014 Syzygium aromaticum Species 0.000 claims description 5
- 240000007313 Tilia cordata Species 0.000 claims description 5
- 240000001717 Vaccinium macrocarpon Species 0.000 claims description 5
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 claims description 5
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 claims description 5
- 235000009754 Vitis X bourquina Nutrition 0.000 claims description 5
- 235000012333 Vitis X labruscana Nutrition 0.000 claims description 5
- 240000006365 Vitis vinifera Species 0.000 claims description 5
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 5
- 235000004634 cranberry Nutrition 0.000 claims description 5
- 235000013399 edible fruits Nutrition 0.000 claims description 5
- 235000020333 oolong tea Nutrition 0.000 claims description 5
- 240000003538 Chamaemelum nobile Species 0.000 claims description 4
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims description 4
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 4
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 4
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 4
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 4
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 4
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 4
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 4
- 240000000171 Crataegus monogyna Species 0.000 claims description 4
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 4
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 4
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 4
- 235000011201 Ginkgo Nutrition 0.000 claims description 4
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 4
- 244000194101 Ginkgo biloba Species 0.000 claims description 4
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 4
- 244000284380 Hibiscus rosa sinensis Species 0.000 claims description 4
- 241000546188 Hypericum Species 0.000 claims description 4
- 235000017309 Hypericum perforatum Nutrition 0.000 claims description 4
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims description 4
- 244000178231 Rosmarinus officinalis Species 0.000 claims description 4
- 235000002953 Saxifraga stolonifera Nutrition 0.000 claims description 4
- 244000288377 Saxifraga stolonifera Species 0.000 claims description 4
- 235000005865 Symphytum officinale Nutrition 0.000 claims description 4
- 240000002299 Symphytum officinale Species 0.000 claims description 4
- 244000273928 Zingiber officinale Species 0.000 claims description 4
- YRXGUZPUZBCGST-UHFFFAOYSA-N [2-(hydroxymethoxy)phenyl]-phenylmethanone Chemical compound OCOC1=CC=CC=C1C(=O)C1=CC=CC=C1 YRXGUZPUZBCGST-UHFFFAOYSA-N 0.000 claims description 4
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 claims description 4
- 229960001173 oxybenzone Drugs 0.000 claims description 4
- LYKRPDCJKSXAHS-UHFFFAOYSA-N phenyl-(2,3,4,5-tetrahydroxyphenyl)methanone Chemical compound OC1=C(O)C(O)=CC(C(=O)C=2C=CC=CC=2)=C1O LYKRPDCJKSXAHS-UHFFFAOYSA-N 0.000 claims description 4
- 235000013616 tea Nutrition 0.000 claims description 4
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 claims description 3
- 241000157282 Aesculus Species 0.000 claims description 3
- 241000252229 Carassius auratus Species 0.000 claims description 3
- 235000005940 Centaurea cyanus Nutrition 0.000 claims description 3
- 240000004385 Centaurea cyanus Species 0.000 claims description 3
- 241000951471 Citrus junos Species 0.000 claims description 3
- 241000195955 Equisetum hyemale Species 0.000 claims description 3
- 241000208690 Hamamelis Species 0.000 claims description 3
- 240000000982 Malva neglecta Species 0.000 claims description 3
- 235000000060 Malva neglecta Nutrition 0.000 claims description 3
- 241001529735 Melissa Species 0.000 claims description 3
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 3
- 244000170916 Paeonia officinalis Species 0.000 claims description 3
- 235000009108 Urtica dioica Nutrition 0.000 claims description 3
- 244000274883 Urtica dioica Species 0.000 claims description 3
- 235000020279 black tea Nutrition 0.000 claims description 3
- 235000010181 horse chestnut Nutrition 0.000 claims description 3
- 241000555825 Clupeidae Species 0.000 claims description 2
- 241000196324 Embryophyta Species 0.000 claims description 2
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 2
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 2
- 244000207740 Lemna minor Species 0.000 claims description 2
- 235000006439 Lemna minor Nutrition 0.000 claims description 2
- 235000001855 Portulaca oleracea Nutrition 0.000 claims description 2
- 229940010454 licorice Drugs 0.000 claims description 2
- 235000002020 sage Nutrition 0.000 claims description 2
- 235000019512 sardine Nutrition 0.000 claims description 2
- 241000086254 Arnica montana Species 0.000 claims 1
- 244000003416 Asparagus officinalis Species 0.000 claims 1
- 235000005340 Asparagus officinalis Nutrition 0.000 claims 1
- 235000009113 Betula papyrifera Nutrition 0.000 claims 1
- 235000009109 Betula pendula Nutrition 0.000 claims 1
- 244000089654 Betula populifolia Species 0.000 claims 1
- 235000010928 Betula populifolia Nutrition 0.000 claims 1
- 235000002992 Betula pubescens Nutrition 0.000 claims 1
- 241000258920 Chilopoda Species 0.000 claims 1
- 240000000560 Citrus x paradisi Species 0.000 claims 1
- 244000004281 Eucalyptus maculata Species 0.000 claims 1
- 240000004670 Glycyrrhiza echinata Species 0.000 claims 1
- 241000218228 Humulus Species 0.000 claims 1
- 241000121185 Monodon monoceros Species 0.000 claims 1
- 241000004960 Sambucus mexicana Species 0.000 claims 1
- 230000006641 stabilisation Effects 0.000 claims 1
- 238000011105 stabilization Methods 0.000 claims 1
- 210000003491 skin Anatomy 0.000 abstract description 26
- 238000004519 manufacturing process Methods 0.000 abstract description 8
- 239000006096 absorbing agent Substances 0.000 abstract description 6
- 210000002615 epidermis Anatomy 0.000 abstract description 2
- 230000003780 keratinization Effects 0.000 abstract description 2
- 150000002926 oxygen Chemical class 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 19
- 239000000194 fatty acid Substances 0.000 description 19
- 229930195729 fatty acid Natural products 0.000 description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- 230000002000 scavenging effect Effects 0.000 description 9
- 239000000523 sample Substances 0.000 description 7
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 6
- 229910019142 PO4 Inorganic materials 0.000 description 6
- 239000006210 lotion Substances 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 235000021317 phosphate Nutrition 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 230000009759 skin aging Effects 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- 229940058015 1,3-butylene glycol Drugs 0.000 description 3
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 3
- 235000015701 Artemisia arbuscula Nutrition 0.000 description 3
- 235000002657 Artemisia tridentata Nutrition 0.000 description 3
- 235000018185 Betula X alpestris Nutrition 0.000 description 3
- 235000018212 Betula X uliginosa Nutrition 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 244000303040 Glycyrrhiza glabra Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 229960005309 estradiol Drugs 0.000 description 3
- 229930182833 estradiol Natural products 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 3
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 2
- AFDXODALSZRGIH-QPJJXVBHSA-N (E)-3-(4-methoxyphenyl)prop-2-enoic acid Chemical compound COC1=CC=C(\C=C\C(O)=O)C=C1 AFDXODALSZRGIH-QPJJXVBHSA-N 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- ZFGOPJASRDDARH-UHFFFAOYSA-N 3-[[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthrene Chemical compound C12CCC3(C)C(C(C)CCCC(C)C)CCC3C2CC=C(C2)C1(C)CCC2OC1CC2=CCC3C4CCC(C(C)CCCC(C)C)C4(C)CCC3C2(C)CC1 ZFGOPJASRDDARH-UHFFFAOYSA-N 0.000 description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- 241000208983 Arnica Species 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- 241001416153 Bos grunniens Species 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- 235000004032 Centella asiatica Nutrition 0.000 description 2
- 244000146462 Centella asiatica Species 0.000 description 2
- 241000723346 Cinnamomum camphora Species 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- FWKQNCXZGNBPFD-UHFFFAOYSA-N Guaiazulene Chemical compound CC(C)C1=CC=C(C)C2=CC=C(C)C2=C1 FWKQNCXZGNBPFD-UHFFFAOYSA-N 0.000 description 2
- 235000008694 Humulus lupulus Nutrition 0.000 description 2
- 244000025221 Humulus lupulus Species 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 240000007472 Leucaena leucocephala Species 0.000 description 2
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 235000003142 Sambucus nigra Nutrition 0.000 description 2
- 240000006028 Sambucus nigra Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 108010093894 Xanthine oxidase Proteins 0.000 description 2
- 102100033220 Xanthine oxidase Human genes 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- 229960000686 benzalkonium chloride Drugs 0.000 description 2
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical group CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 2
- 235000021028 berry Nutrition 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 235000015155 buttermilk Nutrition 0.000 description 2
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 2
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 2
- 229960002079 calcium pantothenate Drugs 0.000 description 2
- 229960000846 camphor Drugs 0.000 description 2
- 229930008380 camphor Natural products 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000002826 coolant Substances 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 2
- 235000008995 european elder Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000003779 hair growth Effects 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229960000890 hydrocortisone Drugs 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000011477 liquorice Nutrition 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- RGOVYLWUIBMPGK-UHFFFAOYSA-N nonivamide Chemical compound CCCCCCCCC(=O)NCC1=CC=C(O)C(OC)=C1 RGOVYLWUIBMPGK-UHFFFAOYSA-N 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 239000003223 protective agent Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 102220240796 rs553605556 Human genes 0.000 description 2
- 229940112950 sage extract Drugs 0.000 description 2
- 235000020752 sage extract Nutrition 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 235000010199 sorbic acid Nutrition 0.000 description 2
- 239000004334 sorbic acid Substances 0.000 description 2
- 229940075582 sorbic acid Drugs 0.000 description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 229940098465 tincture Drugs 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 1
- 239000001149 (9Z,12Z)-octadeca-9,12-dienoate Substances 0.000 description 1
- WTTJVINHCBCLGX-UHFFFAOYSA-N (9trans,12cis)-methyl linoleate Natural products CCCCCC=CCC=CCCCCCCCC(=O)OC WTTJVINHCBCLGX-UHFFFAOYSA-N 0.000 description 1
- UAFHRUBCOQPFFM-UHFFFAOYSA-N 1-(aminomethyl)cyclohexane-1-carboxylic acid Chemical compound NCC1(C(O)=O)CCCCC1 UAFHRUBCOQPFFM-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- NKBCSLFQNACMGL-UHFFFAOYSA-N 2,2-dichloro-2-[di(propan-2-yl)amino]acetic acid Chemical compound CC(C)N(C(C)C)C(Cl)(Cl)C(O)=O NKBCSLFQNACMGL-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- IZLVFLOBTPURLP-UHFFFAOYSA-N 2-Methoxy-4-nitrophenol Chemical compound COC1=CC([N+]([O-])=O)=CC=C1O IZLVFLOBTPURLP-UHFFFAOYSA-N 0.000 description 1
- RVBUGGBMJDPOST-UHFFFAOYSA-N 2-thiobarbituric acid Chemical compound O=C1CC(=O)NC(=S)N1 RVBUGGBMJDPOST-UHFFFAOYSA-N 0.000 description 1
- LNJCGNRKWOHFFV-UHFFFAOYSA-N 3-(2-hydroxyethylsulfanyl)propanenitrile Chemical compound OCCSCCC#N LNJCGNRKWOHFFV-UHFFFAOYSA-N 0.000 description 1
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- CFKMVGJGLGKFKI-UHFFFAOYSA-N 4-chloro-m-cresol Chemical compound CC1=CC(O)=CC=C1Cl CFKMVGJGLGKFKI-UHFFFAOYSA-N 0.000 description 1
- TZZAKSLHHIJRLL-UHFFFAOYSA-N 4-hydroxy-3-methoxybenzamide Chemical compound COC1=CC(C(N)=O)=CC=C1O TZZAKSLHHIJRLL-UHFFFAOYSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 1
- 241001219293 Aspalathus Species 0.000 description 1
- 229930192334 Auxin Natural products 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- DFERZTIWCDQJHJ-AXDSSHIGSA-N CCOC(=O)C(C(C)=O)CNC(=O)[C@H](O)C(C)(C)CO Chemical compound CCOC(=O)C(C(C)=O)CNC(=O)[C@H](O)C(C)(C)CO DFERZTIWCDQJHJ-AXDSSHIGSA-N 0.000 description 1
- 235000003880 Calendula Nutrition 0.000 description 1
- 240000001432 Calendula officinalis Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000131283 Cantharis Species 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical class NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- VQAWRQZAAIQXHM-UHFFFAOYSA-N Cepharanthine Natural products O1C(C=C2)=CC=C2CC(C=23)N(C)CCC3=CC=3OCOC=3C=2OC(=CC=23)C(OC)=CC=2CCN(C)C3CC2=CC=C(O)C1=C2 VQAWRQZAAIQXHM-UHFFFAOYSA-N 0.000 description 1
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
- 108010036949 Cyclosporine Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- ILKBHIBYKSHTKQ-UHFFFAOYSA-N Diisopropylamine dichloroacetate Chemical compound OC(=O)C(Cl)Cl.CC(C)NC(C)C ILKBHIBYKSHTKQ-UHFFFAOYSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 241000195950 Equisetum arvense Species 0.000 description 1
- 239000005768 Equisetum arvense L. Substances 0.000 description 1
- 241000511010 Eustoma Species 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 241000218033 Hibiscus Species 0.000 description 1
- 235000013719 Houttuynia cordata Nutrition 0.000 description 1
- 240000000691 Houttuynia cordata Species 0.000 description 1
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- PKIXXJPMNDDDOS-UHFFFAOYSA-N Methyl linoleate Natural products CCCCC=CCCC=CCCCCCCCC(=O)OC PKIXXJPMNDDDOS-UHFFFAOYSA-N 0.000 description 1
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 244000115721 Pennisetum typhoides Species 0.000 description 1
- 235000007195 Pennisetum typhoides Nutrition 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical class C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- 235000008515 Setaria glauca Nutrition 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 235000020759 St. John’s wort extract Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 241000269959 Xiphias gladius Species 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000003679 aging effect Effects 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001414 amino alcohols Chemical class 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 229960002298 aminohydroxybutyric acid Drugs 0.000 description 1
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940053200 antiepileptics fatty acid derivative Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 239000002363 auxin Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 150000001277 beta hydroxy acids Chemical class 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000008338 calamine lotion Substances 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- YVPXVXANRNDGTA-WDYNHAJCSA-N cepharanthine Chemical compound C1C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@H](C2=C3)N(C)CCC2=CC(OC)=C3OC2=C(OCO3)C3=CC3=C2[C@H]1N(C)CC3 YVPXVXANRNDGTA-WDYNHAJCSA-N 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 150000001789 chalcones Chemical class 0.000 description 1
- 235000005513 chalcones Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001841 cholesterols Chemical class 0.000 description 1
- 229940006423 chondroitin sulfate sodium Drugs 0.000 description 1
- 229960001265 ciclosporin Drugs 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 229920002770 condensed tannin Polymers 0.000 description 1
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 229930182912 cyclosporin Natural products 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- NZZIMKJIVMHWJC-UHFFFAOYSA-N dibenzoylmethane Chemical compound C=1C=CC=CC=1C(=O)CC(=O)C1=CC=CC=C1 NZZIMKJIVMHWJC-UHFFFAOYSA-N 0.000 description 1
- 229940084113 diisopropylamine dichloroacetate Drugs 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 description 1
- 229940009662 edetate Drugs 0.000 description 1
- 210000003278 egg shell Anatomy 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003949 flavanone Natural products 0.000 description 1
- 150000002208 flavanones Chemical class 0.000 description 1
- 235000011981 flavanones Nutrition 0.000 description 1
- 229930003939 flavanonol Natural products 0.000 description 1
- 150000002210 flavanonols Chemical class 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 150000002216 flavonol derivatives Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- YQGDEPYYFWUPGO-UHFFFAOYSA-N gamma-amino-beta-hydroxybutyric acid Chemical compound [NH3+]CC(O)CC([O-])=O YQGDEPYYFWUPGO-UHFFFAOYSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- 229960002350 guaiazulen Drugs 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- WYVGZXIHGGQSQN-UHFFFAOYSA-N hexadecanoate;tris(2-hydroxyethyl)azanium Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCCCCCC(O)=O WYVGZXIHGGQSQN-UHFFFAOYSA-N 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 229920001461 hydrolysable tannin Polymers 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 150000002462 imidazolines Chemical class 0.000 description 1
- 150000004693 imidazolium salts Chemical class 0.000 description 1
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000000077 insect repellent Substances 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- VLPIATFUUWWMKC-UHFFFAOYSA-N mexiletine Chemical compound CC(N)COC1=C(C)C=CC=C1C VLPIATFUUWWMKC-UHFFFAOYSA-N 0.000 description 1
- 229960001070 mexiletine hydrochloride Drugs 0.000 description 1
- 229960003632 minoxidil Drugs 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- JPXMTWWFLBLUCD-UHFFFAOYSA-N nitro blue tetrazolium(2+) Chemical compound COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 JPXMTWWFLBLUCD-UHFFFAOYSA-N 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- HMNQKNBOXPSFDQ-UHFFFAOYSA-N pentadecanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCCCCCCCCC(O)=O HMNQKNBOXPSFDQ-UHFFFAOYSA-N 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 238000005325 percolation Methods 0.000 description 1
- 229940083254 peripheral vasodilators imidazoline derivative Drugs 0.000 description 1
- 229940067631 phospholipid Drugs 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- IYDGMDWEHDFVQI-UHFFFAOYSA-N phosphoric acid;trioxotungsten Chemical compound O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.OP(O)(O)=O IYDGMDWEHDFVQI-UHFFFAOYSA-N 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- BTSZTGGZJQFALU-UHFFFAOYSA-N piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 description 1
- 229940081510 piroctone olamine Drugs 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000004300 potassium benzoate Substances 0.000 description 1
- 235000010235 potassium benzoate Nutrition 0.000 description 1
- 229940103091 potassium benzoate Drugs 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 1
- 229960001755 resorcinol Drugs 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 150000004609 retinol derivatives Chemical class 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 229940099416 st. john's wort extract Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 235000021335 sword fish Nutrition 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 1
- 229960001325 triclocarban Drugs 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000003357 wound healing promoting agent Substances 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
- 229940043810 zinc pyrithione Drugs 0.000 description 1
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 1
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【0001】[0001]
【発明が属する技術分野】本発明は活性酸素消去剤及び
皮膚化粧料に関し、更に詳しくは、表皮の角質化を促進
し、更に活性酸素を消去し皮膚での過酸化脂質の生成を
抑制することにより、優れた皮膚老化防止効果を持つ活
性酸素消去剤並びに皮膚化粧料に関する。TECHNICAL FIELD The present invention relates to an active oxygen scavenger and a skin cosmetic, and more specifically, it promotes keratinization of the epidermis and further eliminates active oxygen to suppress the production of lipid peroxide in the skin. Relates to an active oxygen scavenger and a skin cosmetic having an excellent effect of preventing skin aging.
【0002】[0002]
【従来の技術】老化した皮膚では過酸化脂質が増大し、
柔軟性、弾力性を失い、皮膚のしわが増大し、乾燥して
滑らかさのない荒れ肌症状が認められている。これらの
皮膚症状が現れる原因物質の一つとして、大気中の酸素
が紫外線や酵素等の影響を受けて生成するいわゆる活性
酸素が考えられている。このような活性酸素には、スー
パーオキシド、ヒドロキシラジカル、一重項酸素、過酸
化水素等がある。この活性酸素は脂肪酸を酸化し、過酸
化物を生成させる。その上、生成した過酸化物と活性酸
素は、生体に対してコラーゲン線維の架橋、ヒアルロン
酸の断片化、DNA螺旋の部分開裂、連鎖的ラジカルの
発生による組織の損傷等の悪影響を及ぼし、その結果と
して、皮膚のしわや弾力消失、脱毛といった生体の老化
を促進するといわれている。したがって、活性酸素を消
去することは、皮膚の老化を改善あるいは予防する点で
皮膚にとって非常に重要なことであり、皮膚化粧料に求
められる重要な要素である。そのため、従来、生体内に
発生した活性酸素を消去する作用のある物質の探索が広
く行われてきた。この様な作用を有する物質として、従
来用いられてきたものとしては、天然物由来のもので
は、脂溶性のトコフェロール(ビタミンE)、水溶性の
アスコルビン酸(ビタミンC)等が挙げられ、合成化合
物では、BHT(ブチルヒドロキシトルエン)、BHA
(ブチルヒドロキシアニソール)等が挙げられる。ま
た、植物エキスの中にも活性酸素を消去する作用を有す
るものがあり、この作用は主にそのエキス中に含まれる
フラボノイドやタンニンが分子内に有するフェノール性
のOH基に由来するものであると考えられる。したがっ
て、従来より、このような植物エキスを化粧料中に配合
して、活性酸素を消去し、皮膚の老化を防止しようとす
る試みがなされてきた。2. Description of the Related Art Lipid peroxide increases in aged skin,
Loss of flexibility and elasticity, increased wrinkles of the skin, and dry and non-rough rough skin symptoms are observed. As one of the causative substances causing these skin symptoms, so-called active oxygen, which is generated by the influence of ultraviolet rays, enzymes, etc. on oxygen in the atmosphere, is considered. Such active oxygen includes superoxide, hydroxy radical, singlet oxygen, hydrogen peroxide and the like. This active oxygen oxidizes fatty acids and produces peroxides. Moreover, the generated peroxide and active oxygen exert adverse effects on the living body such as cross-linking of collagen fibers, fragmentation of hyaluronic acid, partial cleavage of DNA helix, and tissue damage due to generation of chained radicals. As a result, it is said to promote aging of the body such as wrinkles, loss of elasticity and hair loss. Therefore, elimination of active oxygen is very important for the skin in terms of improving or preventing skin aging, and is an important factor required for skin cosmetics. Therefore, conventionally, a search for a substance having an action of eliminating active oxygen generated in the living body has been widely performed. Examples of substances that have been conventionally used as substances having such actions include natural-derived substances such as fat-soluble tocopherol (vitamin E) and water-soluble ascorbic acid (vitamin C). Then, BHT (butyl hydroxytoluene), BHA
(Butyl hydroxyanisole) and the like. In addition, some plant extracts have an action of eliminating active oxygen, and this action is mainly derived from the phenolic OH group in the molecule of flavonoids and tannins contained in the extract. it is conceivable that. Therefore, conventionally, it has been attempted to blend such a plant extract in a cosmetic composition to eliminate active oxygen and prevent skin aging.
【0003】[0003]
【発明が解決しようとする課題】しかしながら、発明者
らは、このような植物エキス中のフラボノイド及び/又
はタンニンは安定性が悪く、例えば紫外線によってその
活性酸素消去能が低下してしまうという問題点を見出し
た。これは、紫外線照射により、活性部位であるフェノ
ール性のOH基による分子間結合が起こり、それによっ
て活性部位が封鎖されてしまうことが原因であると考え
られる。However, the present inventors have a problem that the flavonoids and / or tannins in such a plant extract have poor stability and, for example, their ability to eliminate active oxygen is reduced by ultraviolet rays. Found. It is considered that this is because the ultraviolet irradiation causes intermolecular bonding due to the phenolic OH group, which is the active site, thereby blocking the active site.
【0004】そこで、本発明はフラボノイド及び/又は
タンニンを含有する植物エキスを配合した活性酸素消去
剤における上記の問題を解決することを目的とする。Therefore, an object of the present invention is to solve the above problems in an active oxygen scavenger containing a plant extract containing flavonoids and / or tannins.
【0005】[0005]
【課題を解決するための手段】本発明者らが鋭意検討し
たところ、該植物エキスとともに可溶化された油溶性紫
外線吸収剤を配合させることで、該エキス中のフラボノ
イド及び/又はタンニンの示す活性酸素消去能の低下が
防止され、より安定な活性酸素消去剤を得る事ができ
た。また、驚くべきことに、油溶性紫外線吸収剤は、単
にその製剤中に配合するだけではこのような効果を発揮
せず、適切な可溶化剤により製剤中に可溶化することに
よって、このような効果を発揮することがわかった。す
なわち、本発明はフラボノイド及び/又はタンニンを含
有する植物エキスと、該植物エキスの活性酸素消去能を
維持するための可溶化された油溶性紫外線吸収剤を含む
ことを特徴とする、紫外線に対して安定な活性酸素消去
剤である。また、このような活性酸素消去剤からなる老
化防止用皮膚化粧料である。Means for Solving the Problems The inventors of the present invention have made extensive studies, and as a result of incorporating a solubilized oil-soluble ultraviolet absorber together with the plant extract, the activity of flavonoids and / or tannins in the extract is exhibited. A decrease in oxygen scavenging ability was prevented, and a more stable active oxygen scavenger could be obtained. Surprisingly, the oil-soluble UV absorber does not exert such an effect when it is simply added to the formulation, and by solubilizing it in the formulation with an appropriate solubilizer, It turned out to be effective. That is, the present invention is characterized in that it contains a plant extract containing flavonoids and / or tannins, and a solubilized oil-soluble UV absorber for maintaining the active oxygen scavenging ability of the plant extract. And stable active oxygen scavenger. Further, it is an anti-aging skin cosmetic which comprises such an active oxygen scavenger.
【0006】本発明の活性酸素消去剤の一実施態様は、
フラボノイド及び/又はタンニンを含有する植物エキス
を乾燥残分換算で好ましくは0.0001〜5質量%
と、可溶化された油溶性紫外線吸収剤を同じく乾燥残分
換算で好ましくは0.0001〜5質量%含むことを特
徴とする活性酸素消去剤である。One embodiment of the active oxygen scavenger of the present invention is
The plant extract containing flavonoids and / or tannins is preferably 0.0001 to 5 mass% in terms of dry residue.
And a solubilized oil-soluble UV absorber, which is also preferably contained in an amount of 0.0001 to 5% by mass in terms of dry residue, which is an active oxygen scavenger.
【0007】本発明の好ましい実施態様において、前記
植物エキスが、アシタバ、アスパラサスリネアリス、ア
センヤク、アルニカ、イチョウ、イラクサ、ウーロン
茶、エイジツ、オウゴン、オトギリソウ、カミツレ、カ
ワラヨモギ、カンゾウ、キンギンカ、クランベリーの
実、クララ、ゲンノショウコ、紅茶、コンフリー、サボ
ンソウ、サンザシ、シナノキ、シャクヤク、シラカバ、
スギナ、セイヨウキズタ、セイヨウニワトコ、セイヨウ
ネズ、セイヨウハッカ、セージ、ゼニアオイ、チャ、チ
ョウジ、チンピ、ツボクサ、テンチャ、トウキンセン
カ、ドクダミ、ニンドウ、ノバラ、ハイビスカスの花、
ハマメリス、ヒキオコシ、ブドウ葉、ブドウの実、ボタ
ン、ホップ、マロニエ、メリッサ、モモ葉、ヤグルマギ
ク、ユキノシタ、ユズ、ヨモギ、ローズマリー、ワレモ
コウ、からなる群より選ばれる少なくとも1種である。
また、前記油溶性紫外線吸収剤が、パラアミノ安息香酸
エチル、パラジメチルアミノ安息香酸オクチル、パラメ
トキシケイ皮酸オクチル、ヒドロキシメトキシベンゾフ
ェノン(オキシベンゾン)、テトラヒドロキシベンゾフ
ェノン、4-t-ブチル-4-メトキシ-ジベンゾイルメタ
ン、2-(2-ヒドロキシ-5-メチルフェニル)ベンゾト
リアゾール及びその誘導体からなる群より選ばれる少な
くとも1種であることが好ましい。[0007] In a preferred embodiment of the present invention, the plant extract comprises ashitaba, aspalathus linealis, acacia yak, arnica, ginkgo, nettle, oolong tea, ages, sardines, hypericum, chamomile, sagebrush, liquorice, goldfish, cranberry fruit, Clara, ginger ginger, black tea, comfrey, soapless, hawthorn, linden, peony, birch,
Horsetail, Eustoma japonicus, Sambucus nigra, Eurasian mud, Eurasian peppermint, sage, mallow, tea, clove, chinpi, Centella asiatica, Tencha, Tofu calendula, Dokudami, Nindou, Novara, Hibiscus flower,
It is at least one species selected from the group consisting of hamamelis, hikoshi, vine leaves, grape berries, buttons, hops, horse chestnuts, melissa, peach leaves, cornflowers, yukinoshita, yuzu, mugwort, rosemary, waremoko.
Further, the oil-soluble ultraviolet absorber is ethyl paraaminobenzoate, octyl paradimethylaminobenzoate, octyl paramethoxycinnamate, hydroxymethoxybenzophenone (oxybenzone), tetrahydroxybenzophenone, 4-t-butyl-4-methoxy-. It is preferably at least one selected from the group consisting of dibenzoylmethane, 2- (2-hydroxy-5-methylphenyl) benzotriazole and its derivatives.
【0008】[0008]
【発明の実施の形態】本発明において使用される植物エ
キスは、フラボノイド及び/又はタンニンを含むもので
あることを特徴とする。フラボノイドには、フラボン
類、フラボノール類、イソフラボン類、フラバノン類、
フラバノノール類、カルコン類、ベンザルクマラノン
類、アントシアン類の化合物およびそれらの配糖体が含
まれる。また、タンニンには加水分解性タンニンと縮合
型タンニンの双方が含まれる。BEST MODE FOR CARRYING OUT THE INVENTION The plant extract used in the present invention is characterized by containing flavonoids and / or tannins. Flavonoids include flavones, flavonols, isoflavones, flavanones,
Compounds of flavanonols, chalcones, benzalcumalanones, anthocyans and their glycosides are included. Further, the tannin includes both hydrolyzable tannin and condensed tannin.
【0009】本発明において使用される植物エキスとし
ては、例えば、アシタバ、アスパラサスリネアリス、ア
センヤク、アルニカ、イチョウ、イラクサ、ウーロン
茶、エイジツ、オウゴン、オトギリソウ、カミツレ、カ
ワラヨモギ、カンゾウ、キンギンカ、クランベリーの
実、クララ、ゲンノショウコ、紅茶、コンフリー、サボ
ンソウ、サンザシ、シナノキ、シャクヤク、シラカバ、
スギナ、セイヨウキズタ、セイヨウニワトコ、セイヨウ
ネズ、セイヨウハッカ、セージ、ゼニアオイ、チンピ、
ツボクサ、テンチャ、チャ、チョウジ、トウキンセン
カ、ドクダミ、ニンドウ、ノバラ、ハイビスカスの花、
ハマメリス、ヒキオコシ、ブドウ葉、ブドウの実、ボタ
ン、ホップ、マロニエ、メリッサ、モモ葉、ヤグルマギ
ク、ユキノシタ、ユズ、ヨモギ、ローズマリー、ワレモ
コウ、などが挙げられる。好ましくは、ウーロン茶、オ
トギリソウ、カミツレ、カワラヨモギ、カンゾウ、ゲン
ノショウコ、クランベリーの実、コンフリー、サンザ
シ、シナノキ、シラカバ、テンチャ、ブドウ葉、ボタ
ン、ハイビスカスの花、モモ葉、ユキノシタ、ローズマ
リー、チャ、チョウジが使用され、なかでもウーロン
茶、シナノキ、テンチャ、ブドウ葉、モモ葉、チョウ
ジ、クランベリーの実、及びハイビスカスの花が特に好
ましい。The plant extract used in the present invention includes, for example, ashitaba, asparasus linealis, acacia yak, arnica, ginkgo, nettle, oolong tea, aget, swordfish, gentian, chamomile, sagebrush, licorice, goldfish, cranberry fruit, Clara, ginger ginger, black tea, comfrey, soapless, hawthorn, linden, peony, birch,
Horsetail, Equisetum arvense, Sambucus nigra, Horseshoe, Mint, Sage, mallow, cock,
Centella asiatica, tencha, tea, clove, pearl millet, duckweed, nindo, nobara, hibiscus flower,
Examples include hamamelis, hikoshi, vine leaves, grape berries, buttons, hops, horse chestnuts, melissa, peach leaves, cornflowers, yukinoshita, yuzu, mugwort, rosemary, waremoko, and the like. Preferably, oolong tea, hypericum, chamomile, sagebrush, liquorice, ginger ginger, cranberry fruit, comfrey, hawthorn, linden, birch, tencha, grape leaf, button, hibiscus flower, peach leaf, yukinoshita, rosemary, tea, clove Among them, oolong tea, linden, tencha, grape leaf, peach leaf, clove, cranberry fruit, and hibiscus flower are particularly preferable.
【0010】該植物エキスの調製方法には特に制限はな
いが、通常、植物のいずれかの部位、例えば全草、根、
茎、花、を乾燥、細断等し、次いで、水、メタノール、
エタノール、プロパノール、プロピレングリコール、及
び1,3−ブチレングリコール、酢酸エチル、エーテル、
流動パラフィン、大豆油、低級脂肪酸グリセリド、また
は、これらの混合溶媒で、浸出法もしくはパーコレーシ
ョン法により抽出して得られる。得られた抽出物は、液
状、軟稠エキス状、ゲル状、乾燥エキス状のいずれの形
態で供されてもよい。There is no particular limitation on the method for preparing the plant extract, but usually, any part of the plant such as whole grass, roots,
Dry stems, flowers, shreds, etc., then water, methanol,
Ethanol, propanol, propylene glycol, and 1,3-butylene glycol, ethyl acetate, ether,
It is obtained by extraction with liquid paraffin, soybean oil, lower fatty acid glyceride, or a mixed solvent thereof by a leaching method or a percolation method. The obtained extract may be provided in any form of liquid, soft extract, gel and dry extract.
【0011】該植物エキスの配合量には、特に制限はな
く、化粧料および植物エキスの効能等に応じて適宜選定
することができる。通常、乾燥残分換算で0.0001
〜5質量%で活性酸素消去剤又は老化防止用皮膚化粧料
に配合されることが好ましい。The blending amount of the plant extract is not particularly limited and can be appropriately selected depending on the efficacy of the cosmetic and the plant extract. Usually 0.0001 in terms of dry residue
It is preferable that the active oxygen scavenger or the anti-aging skin cosmetic is mixed in an amount of -5% by mass.
【0012】本発明において活性酸素消去能の安定性
は、確実な評価のために、実際上想定されるよりも厳し
い条件下、すなわち、植物エキス含有水溶液に人工的な
太陽光を連続照射し、その前後の活性酸素消去能を測定
することにより確認した。本発明において、好ましい安
定化剤には、該剤を0.1〜5質量%の濃度で、植物エ
キスの10質量%水溶液に添加することによって、上記
条件下でも、該水溶液の活性酸素消去能が実質的に低下
しない、又は低下しにくいことを可能とする油溶性紫外
線吸収剤が含まれる。In the present invention, the stability of the active oxygen scavenging ability is, for a reliable evaluation, under more severe conditions than actually assumed, that is, an aqueous solution containing a plant extract is continuously irradiated with artificial sunlight, It was confirmed by measuring the active oxygen scavenging ability before and after that. In the present invention, as a preferred stabilizer, by adding the agent at a concentration of 0.1 to 5% by mass to a 10% by mass aqueous solution of a plant extract, the active oxygen scavenging ability of the aqueous solution can be maintained even under the above conditions. The oil-soluble ultraviolet absorber that enables the oil to be substantially or not easily reduced is included.
【0013】本発明における油溶性紫外線吸収剤は単独
で配合しても、複数を組み合わせて配合してもよい。油
溶性紫外線吸収剤としては、パラアミノ安息香酸エチ
ル、パラジメチルアミノ安息香酸オクチル、パラメトキ
シケイ皮酸オクチル、ヒドロキシメトキシベンゾフェノ
ン(別名:オキシベンゾン)、テトラヒドロキシベンゾ
フェノン、4-t-ブチル-4-メトキシ-ジベンゾイルメ
タン、オクチルトリアゾン及びその誘導体が好ましい。The oil-soluble ultraviolet absorber according to the present invention may be blended alone or in combination of two or more. As the oil-soluble ultraviolet absorber, ethyl paraaminobenzoate, octyl paradimethylaminobenzoate, octyl paramethoxycinnamate, hydroxymethoxybenzophenone (also known as oxybenzone), tetrahydroxybenzophenone, 4-t-butyl-4-methoxy- Dibenzoylmethane, octyltriazone and its derivatives are preferred.
【0014】該油溶性紫外線吸収剤の配合量には、特に
制限はなく、化粧料の形態、及び植物エキスの配合量に
応じて適宜選定することができる。好ましくは、活性酸
素消去剤又は老化防止用皮膚化粧料の総量に対し、0.
0001〜5質量%で配合される。該油溶性紫外線吸収
剤は通常化粧料に用いられる可溶化剤によって可溶化さ
れた形態で配合される。また該油溶性紫外線吸収剤の可
溶化剤としては、特にHLBが10以上の非イオン性界
面活性剤が好ましく、例えば、ソルビタン脂肪酸エステ
ル、グリセリン脂肪酸エステル、ポリグリセリン脂肪酸
エステル、プロピレングリコール脂肪酸エステル、ポリ
エチレングリコール脂肪酸エステル、ショ糖脂肪酸エス
テル、ポリオキシエチレンアルキルエーテル、ポリオキ
シプロピレンアルキルエーテル、ポリオキシエチレンア
ルキルフェニルエーテル、ポリオキシエチレン脂肪酸エ
ステル、ポリオキシエチレンソルビタン脂肪酸エステ
ル、ポリオキシエチレンソルビトール脂肪酸エステル、
ポリオキシエチレングリセリン脂肪酸エステル、ポリオ
キシエチレンプロピレングリコール脂肪酸エステル、ポ
リオキシエチレンヒマシ油、ポリオキシエチレン硬化ヒ
マシ油、ポリオキシエチレンフィトスタノールエーテ
ル、ポリオキシエチレンフィトステロールエーテル、ポ
リオキシエチレンコレスタノールエーテル、ポリオキシ
エチレンコレステリルエーテル、アルカノールアミド、
糖エーテル、糖アミド等が挙げられる。その配合量は油
溶性紫外線吸収剤の種類や配合量によって異なるが、活
性酸素消去剤又は老化防止用皮膚化粧料の総量に対し、
0.01〜10質量%が好ましい。The blending amount of the oil-soluble ultraviolet absorber is not particularly limited and can be appropriately selected depending on the form of the cosmetic and the blending amount of the plant extract. Preferably, the total amount of the active oxygen scavenger or the anti-aging skin cosmetic is 0.
It is compounded at 0001 to 5 mass%. The oil-soluble ultraviolet absorber is blended in a solubilized form with a solubilizer usually used in cosmetics. Further, as the solubilizer for the oil-soluble ultraviolet absorber, a nonionic surfactant having an HLB of 10 or more is particularly preferable, and examples thereof include sorbitan fatty acid ester, glycerin fatty acid ester, polyglycerin fatty acid ester, propylene glycol fatty acid ester, and polyethylene. Glycol fatty acid ester, sucrose fatty acid ester, polyoxyethylene alkyl ether, polyoxypropylene alkyl ether, polyoxyethylene alkylphenyl ether, polyoxyethylene fatty acid ester, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene sorbitol fatty acid ester,
Polyoxyethylene glycerin fatty acid ester, polyoxyethylene propylene glycol fatty acid ester, polyoxyethylene castor oil, polyoxyethylene hydrogenated castor oil, polyoxyethylene phytostanol ether, polyoxyethylene phytosterol ether, polyoxyethylene cholestanol ether, polyoxy Ethylene cholesteryl ether, alkanolamide,
Examples include sugar ethers and sugar amides. The blending amount varies depending on the type and blending amount of the oil-soluble ultraviolet absorber, but with respect to the total amount of the active oxygen scavenger or the anti-aging skin cosmetic,
0.01 to 10 mass% is preferable.
【0015】本発明の活性酸素消去剤又は老化防止用皮
膚化粧料では、上記の各成分以外に、通常化粧料に用い
られる油剤、界面活性剤、防腐剤、香料、保湿剤、塩
類、溶媒、中和剤、pH調整剤、昆虫忌避剤、生理活性
成分等の各種成分を使用することができる。In the active oxygen scavenger or anti-aging skin cosmetic of the present invention, in addition to the above-mentioned components, oils, surfactants, preservatives, perfumes, humectants, salts, solvents, which are usually used in cosmetics, Various components such as a neutralizing agent, a pH adjusting agent, an insect repellent, and a physiologically active ingredient can be used.
【0016】界面活性剤としては、上記に記載した非イ
オン性界面活性剤の他、アニオン性、カチオン性、両性
の活性剤があるが、特に制限されるものではなく、通常
の化粧料に使用されるものであれば、いずれのものも使
用することができる。以下に具体的に例示すると、アニ
オン性界面活性剤としては、ステアリン酸ナトリウムや
パルミチン酸トリエタノールアミン等の脂肪酸セッケ
ン、アルキルエーテルカルボン酸及びその塩、アミノ酸
と脂肪酸の縮合等のカルボン酸塩、アルキルスルホン
酸、アルケンスルホン酸塩、脂肪酸エステルのスルホン
酸塩、脂肪酸アミドのスルホン酸塩、アルキルスルホン
酸塩とそのホルマリン縮合物のスルホン酸塩、アルキル
硫酸エステル塩、第二級高級アルコール硫酸エステル
塩、アルキル及びアリルエーテル硫酸エステル塩、脂肪
酸エステルの硫酸エステル塩、脂肪酸アルキロールアミ
ドの硫酸エステル塩、ロート油等の硫酸エステル塩類、
アルキルリン酸塩、エーテルリン酸塩、アルキルアリル
エーテルリン酸塩、アミドリン酸塩、N−アシルアミノ
酸系活性剤等;カチオン性界面活性剤としては、アルキ
ルアミン塩、ポリアミン及びアミノアルコール脂肪酸誘
導体等のアミン塩、アルキル四級アンモニウム塩、芳香
族四級アンモニウム塩、ピリジウム塩、イミダゾリウム
塩等;両性界面活性剤としては、ベタイン、アミノカル
ボン酸塩、イミダゾリン誘導体等が挙げられる。界面活
性剤を用いる場合の配合量としては、化粧料の総量に対
して0.1〜20質量%が好ましく、更に好ましくは
0.5〜10質量%が望ましい。As the surfactant, there are anionic, cationic and amphoteric surfactants in addition to the above-mentioned nonionic surfactants, but they are not particularly limited, and they are used in ordinary cosmetics. Any of the above can be used. Illustrating specifically below, examples of the anionic surfactant include fatty acid soaps such as sodium stearate and triethanolamine palmitate, alkyl ether carboxylic acids and salts thereof, carboxylates such as condensation of amino acids and fatty acids, and alkyls. Sulfonic acid, alkene sulfonate, fatty acid ester sulfonate, fatty acid amide sulfonate, alkyl sulfonate and its formalin condensate sulfonate, alkyl sulfate ester salt, secondary higher alcohol sulfate ester salt, Alkyl and allyl ether sulfate ester salts, fatty acid ester sulfate ester salts, fatty acid alkylolamide sulfate ester salts, fungal oil and other sulfate ester salts,
Alkyl phosphates, ether phosphates, alkyl allyl ether phosphates, amide phosphates, N-acyl amino acid surfactants and the like; cationic surfactants such as alkyl amine salts, polyamines and amino alcohol fatty acid derivatives Amine salts, alkyl quaternary ammonium salts, aromatic quaternary ammonium salts, pyridinium salts, imidazolium salts and the like; amphoteric surfactants include betaine, aminocarboxylic acid salts, imidazoline derivatives and the like. When a surfactant is used, its content is preferably 0.1 to 20% by mass, more preferably 0.5 to 10% by mass, based on the total amount of the cosmetic.
【0017】防腐剤としては、パラオキシ安息香酸アル
キルエステル、安息香酸、安息香酸カリウム、ソルビン
酸、ソルビン酸カリウム、フェノキシエタノール等、抗
菌剤としては、安息香酸、サリチル酸、石炭酸、ソルビ
ン酸、パラオキシ安息香酸アルキルエステル、パラクロ
ルメタクレゾール、ヘキサクロロフェン、塩化ベンザル
コニウム、塩化クロルヘキシジン、トリクロロカルバニ
リド、トリクロサン、感光素、フェノキシエタノール等
がある。As preservatives, alkyl paraoxybenzoate, benzoic acid, potassium benzoate, sorbic acid, potassium sorbate, phenoxyethanol, etc., and as antibacterial agents, benzoic acid, salicylic acid, carboxylic acid, sorbic acid, alkyl paraoxybenzoates. Esters, parachlorometacresol, hexachlorophene, benzalkonium chloride, chlorhexidine chloride, trichlorocarbanilide, triclosan, photosensitizer, phenoxyethanol and the like.
【0018】本発明で用いる生理活性成分としては、皮
膚に塗布した場合に皮膚に何らかの生理活性を与える物
質が挙げられる。例えば、抗炎症剤、老化防止剤、油溶
性紫外線吸収剤以外の紫外線防御剤、ひきしめ剤、抗酸
化剤、発毛剤、育毛剤、保湿剤、血行促進剤、抗菌剤、
殺菌剤、乾燥剤、冷感剤、温感剤、ビタミン類(但し、
ビタミンC及びEを除く)、アミノ酸、創傷治癒促進剤、
刺激緩和剤、鎮痛剤、細胞賦活剤、酵素成分等が挙げら
れる。本発明では、これらの生理活性成分を1種、また
は2種以上配合することが好ましい。Examples of the physiologically active ingredient used in the present invention include substances that give some physiological activity to the skin when applied to the skin. For example, anti-inflammatory agents, anti-aging agents, UV protective agents other than oil-soluble UV absorbers, tightening agents, antioxidants, hair growth agents, hair growth agents, moisturizers, blood circulation promoters, antibacterial agents,
Bactericide, desiccant, cooling agent, warming agent, vitamins (however,
Vitamins C and E are excluded), amino acids, wound healing promoters,
Examples include stimulants, analgesics, cell activators, enzyme components and the like. In the present invention, it is preferable to blend one kind or two or more kinds of these physiologically active ingredients.
【0019】生理活性成分の例としては、デオキシリボ
核酸、ムコ多糖類、ヒアルロン酸ナリウム、コンドロイ
チン硫酸ナトリウム、コラーゲン、エラスチン、キチ
ン、キトサン、加水分解卵殻膜などの生体高分子、エス
トラジオール、エテニルエストラジオールなどのホルモ
ン、アミノ酸、乳酸ナトリウム、尿素、ピロリドンカル
ボン酸ナトリウム、ベタイン、ホエイなどの保湿成分、
スフィンゴ脂質、セラミド、コレステロール、コレステ
ロール誘導体、リン脂質などの油性成分、ε−アミノカ
プロン酸、グリチルリチン酸、β−グリチルレチン酸、
塩化リゾチーム、グアイアズレン、ヒドロコルチゾン、
アラントイントラネキサム酸、アズレン等の抗炎症剤、
ビタミンA、B2、B6、D、パントテン酸カルシウム、
ビオチン、ニコチン酸アミド等のビタミン類、アラント
イン、ジイソプロピルアミンジクロロアセテート、4−
アミノメチルシクロヘキサンカルボン酸等の活性成分、
α−ヒドロキシ酸、β−ヒドロキシ酸、γ−アミノ酪
酸、γ−アミノ−β−ヒドロキシ酪酸、ジイソプロピル
アミノジクロロアセテートなどの細胞賦活剤、γ−オリ
ザノール、レチノール、レチノール誘導体等の創傷治癒
剤、セファランチン、トウガラシチンキ、ヒノキチオー
ル、ヨウ化ニンニクエキス、塩酸ピリドキシン、ニコチ
ン酸、ニコチン酸誘導体、パントテン酸カルシウム、D
−パントテニルアルコール、アセチルパントテニルエチ
ルエーテル、ビオチン、アラントイン、イソプロピルメ
チルフェノール、エストラジオール、エチニルエステラ
ジオール、塩化カプロニウム、塩化ベンザルコニウム、
塩酸ジフェンヒドラミン、タカナール、カンフル、サリ
チル酸、ノニル酸バニリルアミド、ノナン酸バニリルア
ミド、ピロクトンオラミン、ペンタデカン酸グリセリ
ル、l−メントール、カンフルなどの清涼剤、モノニト
ログアヤコール、レゾルシン、γ−アミノ酪酸、塩化ベ
ンゼトニウム、塩酸メキシレチン、オーキシン、女性ホ
ルモン、カンタリスチンキ、シクロスポリン、ジンクピ
リチオン、ヒドロコルチゾン、ミノキシジル、モノステ
アリン酸ポリオキシエチレンソルビタン、ハッカ油、サ
サニシキエキス等の育毛剤等が挙げられる。Examples of physiologically active ingredients are deoxyribonucleic acid, mucopolysaccharides, sodium hyaluronate, chondroitin sulfate sodium, collagen, elastin, chitin, chitosan, biopolymers such as hydrolyzed eggshell membranes, estradiol, etenyl estradiol, etc. Moisturizing ingredients such as hormones, amino acids, sodium lactate, urea, sodium pyrrolidonecarboxylate, betaine, whey,
Oil components such as sphingolipids, ceramides, cholesterol, cholesterol derivatives, phospholipids, ε-aminocaproic acid, glycyrrhizic acid, β-glycyrrhetinic acid,
Lysozyme chloride, guaiazulene, hydrocortisone,
Anti-inflammatory agents such as allanto intranexamic acid and azulene,
Vitamins A, B 2 , B 6 , D, calcium pantothenate,
Biotin, vitamins such as nicotinic acid amide, allantoin, diisopropylamine dichloroacetate, 4-
Active ingredients such as aminomethylcyclohexanecarboxylic acid,
α-hydroxy acid, β-hydroxy acid, γ-aminobutyric acid, γ-amino-β-hydroxybutyric acid, cell activating agents such as diisopropylaminodichloroacetate, γ-oryzanol, retinol, wound healing agents such as retinol derivatives, cepharanthin, Capsicum tincture, hinokitiol, garlic iodide extract, pyridoxine hydrochloride, nicotinic acid, nicotinic acid derivative, calcium pantothenate, D
-Pantothenyl alcohol, acetylpantothenyl ethyl ether, biotin, allantoin, isopropylmethylphenol, estradiol, ethinyl esteradiol, capronium chloride, benzalkonium chloride,
Cooling agents such as diphenhydramine hydrochloride, tacanal, camphor, salicylic acid, nonyl acid vanillyl amide, nonanoic acid vanillyl amide, piroctone olamine, glyceryl pentadecanoate, l-menthol, camphor, mononitroguaiacol, resorcin, γ-aminobutyric acid, benzethonium chloride, Examples include hair-growing agents such as mexiletine hydrochloride, auxin, female hormone, cantharis tincture, cyclosporine, zinc pyrithione, hydrocortisone, minoxidil, polyoxyethylene sorbitan monostearate, peppermint oil, and sasanishiki extract.
【0020】pH調整剤としては、乳酸、グリコール
酸、コハク酸、dl−リンゴ酸、炭酸カリウム、炭酸水
素ナトリウム、炭酸水素アンモニウム、リン酸ニ水素カ
リウム、リン酸一水素ナトリウム等が挙げられる。Examples of the pH adjusting agent include lactic acid, glycolic acid, succinic acid, dl-malic acid, potassium carbonate, sodium hydrogen carbonate, ammonium hydrogen carbonate, potassium dihydrogen phosphate, sodium monohydrogen phosphate and the like.
【0021】本発明の活性酸素消去剤又は老化防止用皮
膚化粧料の具体的な用途としては特に限定は無いが、ス
キンケア製品、洗顔製品、頭皮もしくは頭髪用の製品、
紫外線防御製品、フレグランス製品等が好ましいものと
して挙げられ、特に好ましくは老化防止用皮膚化粧料が
好ましい。また、その剤型としては油溶性紫外線吸収剤
が可溶化された状態で存在し得る剤型として、ローショ
ン、カラミンローション、サンスクリーン剤、サンタン
剤、アフターシェーブローション、プレシェーブローシ
ョン、パック料、クレンジング料、洗顔料、アクネ対策
化粧料、エッセンスなどの基礎化粧料、シャンプー、リ
ンス、コンディショナー、ヘアカラー、ヘアトニック、
セット剤、育毛剤、デオドラント、ボディーシャンプ
ー、ハンドソープ、香水などがあげられる。The active oxygen scavenger or anti-aging skin cosmetic of the present invention is not particularly limited in specific application, but skin care products, face washing products, scalp or hair products,
UV protection products, fragrance products and the like are mentioned as preferable ones, and antiaging skin cosmetics are particularly preferable. Further, as the dosage form, the oil-soluble UV absorber may be present in a solubilized state, such as lotion, calamine lotion, sunscreen agent, tanning agent, after-shave lotion, pre-shave lotion, pack fee, cleansing agent, Face wash, acne-preventive cosmetics, basic cosmetics such as essence, shampoo, conditioner, hair color, hair tonic,
Examples include setting agents, hair restorers, deodorants, body shampoos, hand soaps, and perfumes.
【0022】[0022]
【実施例】以下、本発明を実施例により詳細に説明する
が、本発明はこれらに限定されるものではない。なお配
合量の単位は質量%で示し、植物エキスについては乾燥
算分換算を用いた。EXAMPLES The present invention will now be described in detail with reference to examples, but the present invention is not limited thereto. The unit of the blending amount is shown by mass%, and the plant extract is calculated by dry calculation.
【0023】試験例1
(活性酸素生成抑制効果および過酸化脂質生成抑制試
験)下記表1の組成の試料を調製してガラス瓶に充填
し、これに低温サンシャインウェザーメーターSL80
(スガ試験機株式会社製)にて5万ジュールの人工太陽
光を照射した。照射後の試料を用い、以下の試験に供し
た。また結果は下記の表2および表3に示した。Test Example 1 (Active oxygen production inhibitory effect and lipid peroxide production inhibitory test) A sample having the composition shown in Table 1 below was prepared and filled in a glass bottle, and the low temperature sunshine weather meter SL80 was added thereto.
(Suga Test Instruments Co., Ltd.) was irradiated with artificial sunlight of 50,000 joules. The sample after irradiation was used for the following tests. The results are shown in Tables 2 and 3 below.
【0024】(1)活性酸素生成抑制試験(NBT法)
0.05mM炭酸ナトリウム緩衝液(pH10.2)
2.4ml、3mMキサンチン0.1ml、3mM E
DTA0.1ml、0.15%牛血清アルブミン0.1
ml、0.75mMニトロブルーテトラゾリウム0.1
mlの組成中に、0.1ml加え、25℃、10分加温
する。そこにバターミルク由来の250倍希釈キサンチ
ンオキシダーゼ(シグマ社製)0.1mlを加え5℃、
20分間反応する。6mM塩化銅0.1ml加え、反応
を停止して分光光度計を用いて波長560nmにて吸光
度を測定した。試料溶液の代わりに、20%エタノール
を0.1ml加えたものの吸光度を100として、抑制
率(%)を求めた。(1) Active oxygen production inhibition test (NBT method) 0.05 mM sodium carbonate buffer (pH 10.2)
2.4 ml, 3 mM xanthine 0.1 ml, 3 mM E
DTA 0.1 ml, 0.15% bovine serum albumin 0.1
ml, 0.75 mM nitroblue tetrazolium 0.1
0.1 ml is added to the composition of ml, and the mixture is heated at 25 ° C. for 10 minutes. Add 250 ml of 250-fold diluted xanthine oxidase (manufactured by Sigma) derived from buttermilk to it, and add it at 5 ° C.
React for 20 minutes. 0.1 ml of 6 mM copper chloride was added, the reaction was stopped, and the absorbance was measured at a wavelength of 560 nm using a spectrophotometer. Instead of the sample solution, 0.1% of 20% ethanol was added, and the absorbance was set to 100 to obtain the inhibition rate (%).
【0025】(2)過酸化脂質生成抑制試験(TBA
法)
上記試料0.4mlに、リノール酸メチル0.3ml、
1mMヒポキサンチン(0.1%Triton X-100含む)
3.0ml、蒸留水0.15ml、バターミルク由来の
20倍希釈キサンチンオキシダーゼ(シグマ社製)0.
15mlの混合溶液を37℃、24時間振盪反応する。
上記組成物0.3mlに10%リンタングステン酸0.
5ml、0.67%チオバルビツール酸1.0mlを加
え攪拌後、95〜100℃、30分間加熱後、急冷して
n−ブタノールを加え振盪攪拌後、遠心(3000rp
m、10分)を行い、上清を分光光度計を用いて波長5
35nmにて吸光度を測定した。試料溶液の代わりに2
0%エタノール0.4ml加えたものの吸光度をコント
ロールとして、コントロールに対する抑制率(%)を求
めた。(2) Lipid peroxide production inhibition test (TBA
Method) 0.3 ml of methyl linoleate was added to 0.4 ml of the above sample,
1 mM hypoxanthine (including 0.1% Triton X-100)
3.0 ml, distilled water 0.15 ml, 20-fold diluted xanthine oxidase derived from buttermilk (manufactured by Sigma).
15 ml of the mixed solution is reacted by shaking at 37 ° C. for 24 hours.
0.3 ml of the above composition contained 0.1% phosphotungstic acid.
5 ml of 0.67% thiobarbituric acid 1.0 ml was added and stirred, heated at 95 to 100 ° C. for 30 minutes, rapidly cooled, n-butanol was added, and the mixture was shaken and stirred, and then centrifuged (3000 rp).
m, 10 minutes), and the supernatant was measured at a wavelength of 5 using a spectrophotometer.
Absorbance was measured at 35 nm. 2 instead of sample solution
Using the absorbance of 0.4 ml of 0% ethanol as a control, the inhibition rate (%) with respect to the control was determined.
【0026】[0026]
【表1】(試料組成) [Table 1] (Sample composition)
【0027】[0027]
【表2】(試験結果A) [Table 2] (Test result A)
【0028】[0028]
【表3】(試験結果B) [Table 3] (Test result B)
【0029】[0029]
【表4】(試験結果C) [Table 4] (Test result C)
【0030】表2(試験結果A)および表3(試験結果
B)から、表中記載のフラボノイド及び/又はタンニン
を含む各植物エキスに対して、油性紫外線吸収剤である
パラジメチルアミノ安息香酸オクチル、パラメトキシケ
イ皮酸オクチル、テトラヒドロキシベンゾフェノン、ヒ
ドロキシメトキシベンゾフェノン(オキシベンゾン)、
4-t-ブチル-4-メトキシ-ジベンゾイルメタン、オク
チルトリアゾンをそれぞれ加えた試料は、該油性紫外線
吸収剤無添加試料に比べ、活性酸素生成抑制と過酸化脂
質生成抑制効果をもつ。なお表4(試験結果C)が示す
様に、上記油性紫外線防御剤単独では、いずれも活性酸
素消去機能が殆ど無い。From Table 2 (test result A) and Table 3 (test result B), for each plant extract containing flavonoids and / or tannins described in the table, octyl paradimethylaminobenzoate, which is an oily ultraviolet absorber, is used. Octyl paramethoxycinnamate, tetrahydroxybenzophenone, hydroxymethoxybenzophenone (oxybenzone),
The samples to which 4-t-butyl-4-methoxy-dibenzoylmethane and octyltriazone were added respectively have an active oxygen production inhibitory effect and a lipid peroxide production inhibitory effect as compared with the sample without the oily ultraviolet absorber. As shown in Table 4 (Test result C), the above-mentioned oily ultraviolet ray protective agents alone have almost no active oxygen scavenging function.
【0031】試験例2
(連用試験)下記の組成にて実施例1、2、比較例1、
2の化粧水を調製してガラス瓶に充填し、これに上記同
様、2万ジュールの人工太陽光を照射した。20名の被
験者を対象として、照射後のそれぞれの試料を別々に左
右の前腕部に、朝夕1回ずつ4週間連続塗布してもら
い、下記の判定基準により各評価項目について評点を出
してもらい、評点の合計値により評価した。サンプルに
は各被験者の左右で異なった試料を塗ってもらうよう設
定し、各試料について各10例の評価ができるようにし
た。Test Example 2 (Continuous test) Examples 1 and 2 and Comparative Example 1 with the following composition
Second lotion was prepared and filled in a glass bottle, which was then irradiated with 20,000 joules of artificial sunlight as above. Targeting 20 subjects, each sample after irradiation was separately applied to the left and right forearms once a day in the morning and evening for 4 weeks continuously, and evaluated for each evaluation item according to the following criteria, It evaluated by the total value of the score. The samples were set so that different samples were applied to the left and right of each subject, so that 10 samples could be evaluated for each sample.
【0032】(判定基準) 3:かなりの改善が見られる。 2:改善が見られる 1:わずかな改善が見られる。 0:改善は無い。(Criteria) 3: Significant improvement is seen. 2: Improvement is seen 1: A slight improvement is seen. 0: There is no improvement.
【0033】 [組成 1] 原 料 成 分 配合量(質量%) 実施例1 比較例1 エタノール 10 10 ポリオキシエチレン硬化ヒマシ油(60EO) 1 1 グリセリン 3 3 1,3ーブチレングリコール 2 2 ジプロピレングリコール 3 3 ポリエチレングリコール1500 1 1 リン酸塩 微量 微量 エデト酸塩 微量 微量 メチルパラベン 微量 微量 オトギリソウエキス 1.0 1.0 パラメトキシケイ皮酸オクチル 0.1 ー 精製水 残量 残量 [0033] [Composition 1] Amount of raw material components (% by mass) Example 1 Comparative example 1 Ethanol 10 10 Polyoxyethylene hydrogenated castor oil (60EO) 1 1 Glycerin 33 1,3-butylene glycol 22 Dipropylene glycol 33 Polyethylene glycol 1500 1 1 Phosphate trace amount trace amount Edetate Trace amount Trace amount Methylparaben Trace amount Trace amount Hypericum extract 1.0 1.0 Paramethoxy cinnamate 0.1- Purified water Remaining amount Remaining amount
【0034】 [組成 2] 原 料 成 分 配合量(質量%) 000 実施例2 比較例2 エタノール 10 10 ポリオキシエチレン硬化ヒマシ油(60EO) 1 1 グリセリン 3 3 1,3ーブチレングリコール 2 2 ジプロピレングリコール 3 3 ポリエチレングリコール1500 1 1 リン酸塩 微量 微量 メチルパラベン 微量 微量 セージエキス 2.0 2.0 パラメトキシケイ皮酸オクチル 0.5 ー 精製水 残量 残量 [0034] [Composition 2] Amount of raw material components (% by mass) 000 Example 2 Comparative Example 2 Ethanol 10 10 Polyoxyethylene hydrogenated castor oil (60EO) 1 1 Glycerin 33 1,3-butylene glycol 22 Dipropylene glycol 33 Polyethylene glycol 1500 1 1 Phosphate trace amount trace amount Methylparaben Trace amount Trace amount Sage extract 2.0 2.0 Paramethoxycinnamate 0.5- Purified water Remaining amount Remaining amount
【0035】[0035]
【表5】(評価結果) [Table 5] (Evaluation results)
【0036】表5の結果が示すように、油溶性紫外線吸
収剤であるパラメトキシケイ皮酸オクチルを、活性酸素
消去能がある植物エキスであるオトギリソウエキスもし
くはセージエキスを含む化粧水に加えると、該化粧水の
皮膚老化防止効果および美肌効果の安定化が確認され
た。As shown in the results in Table 5, when oil-soluble ultraviolet absorber octyl paramethoxycinnamate is added to a lotion containing St. John's wort extract or sage extract, which is a plant extract capable of scavenging active oxygen, It was confirmed that the skin aging preventive effect and the skin beautifying effect of the lotion were stabilized.
【0037】[0037]
【発明の効果】以上示したように、本願発明では、活性
酸素消去能が知られているフラボノイド及び/又はタン
ニンを含む植物エキス含有皮膚化粧料に、油溶性紫外線
吸収剤を並存させることにより、該植物エキスの保存時
及び使用時紫外線によって生じる該活性酸素消去能の低
下を抑制し、該植物エキス含有皮膚化粧料の抗皮膚老化
活性の低下を防ぐことができた。As described above, in the present invention, a plant extract-containing skin cosmetic containing flavonoids and / or tannins known to have active oxygen scavenging ability is allowed to coexist with an oil-soluble ultraviolet absorber, It was possible to suppress the decrease in the active oxygen scavenging ability caused by ultraviolet rays during storage and use of the plant extract, and prevent the decrease in anti-skin aging activity of the skin cosmetic containing the plant extract.
フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61K 35/78 A61K 35/78 B C D F H J K M N Q T V X 47/08 47/08 47/10 47/10 47/14 47/14 47/18 47/18 47/22 47/22 A61P 39/06 A61P 39/06 // A61K 31/352 A61K 31/352 Fターム(参考) 4C076 AA12 BB31 CC18 DD09F DD37A DD38A DD40Q DD45Q DD45R DD49Q DD60Q FF36 FF63 4C083 AA111 AA112 AB282 AC102 AC122 AC342 AC431 AC432 AC471 AC482 AC532 AC841 AD042 AD112 CC04 DD27 EE12 EE13 4C086 AA02 BA08 MA02 MA05 MA63 NA03 ZA89 ZC37 4C088 AA18 AB02 AB03 AB12 AB13 AB16 AB25 AB26 AB29 AB32 AB34 AB38 AB40 AB41 AB44 AB45 AB47 AB51 AB52 AB55 AB56 AB57 AB58 AB59 AB60 AB62 AB66 AB85 AB89 AC01 AC03 AC04 AC05 AC11 BA32 CA05 CA06 CA07 CA08 MA02 MA17 MA63 NA03 ZA89 ZC37Continuation of front page (51) Int.Cl. 7 Identification code FI theme code (reference) A61K 35/78 A61K 35/78 B CD F H H J K M N Q T V X 47/08 47/08 47/10 47/10 47/14 47/14 47/18 47/18 47/22 47/22 A61P 39/06 A61P 39/06 // A61K 31/352 A61K 31/352 F term (reference) 4C076 AA12 BB31 CC18 DD09F DD37A DD38A DD40Q DD45Q DD45R DD49Q DD60Q FF36 FF63 4C083 AA111 AA112 AB282 AC102 AC122 AC342 AC431 AC432 AC471 AC482 AC532 AC841 AD042 AD112 CC04 DD27 EE12 EE13 4C086 AA02 AB08 AB32 AB34 AB34 AB16 AB34 AB16 AB34 AB18 AB32 AB34 AB16 AB32 AB16 AB32 AB16 AB32 AB16 AB16 AB16 AB16 AB41 AB44 AB45 AB47 AB51 AB52 AB55 AB56 AB57 AB58 AB59 AB60 AB62 AB66 AB85 AB89 AC01 AC03 AC04 AC05 AC11 BA32 CA05 CA06 CA07 CA08 MA02 MA17 MA63 NA03 ZA89 ZC37
Claims (6)
する植物エキスおよび水中に可溶化された油溶性紫外線
吸収剤を含むことを特徴とする活性酸素消去剤。1. An active oxygen scavenger comprising a plant extract containing flavonoids and / or tannins and an oil-soluble ultraviolet absorber solubilized in water.
する植物エキスを乾燥残分換算で0.0001〜5質量
%含み、かつ油溶性紫外線吸収剤を0.0001〜5質
量%含むことを特徴とする請求項1記載の活性酸素消去
剤。2. A plant extract containing flavonoids and / or tannins is contained in an amount of 0.0001 to 5% by mass in terms of a dry residue, and an oil-soluble ultraviolet absorber is contained in an amount of 0.0001 to 5% by mass. The active oxygen scavenger according to claim 1.
リネアリス、アセンヤク、アルニカ、イチョウ、イラク
サ、ウーロン茶、エイジツ、オウゴン、オトギリソウ、
カミツレ、カワラヨモギ、カンゾウ、キンギンカ、クラ
ンベリーの実、クララ、ゲンノショウコ、紅茶、コンフ
リー、サボンソウ、サンザシ、シナノキ、シャクヤク、
シラカバ、スギナ、セイヨウキズタ、セイヨウニワト
コ、セイヨウネズ、セイヨウハッカ、セージ、ゼニアオ
イ、チンピ、ツボクサ、テンチャ、チャ、チョウジ、ト
ウキンセンカ、ドクダミ、ニンドウ、ノバラ、ハイビス
カスの花、ハマメリス、ヒキオコシ、ブドウ葉、ブドウ
の実、ボタン、ホップ、マロニエ、メリッサ、モモ葉、
ヤグルマギク、ユキノシタ、ユズ、ヨモギ、ローズマリ
ー、ワレモコウ、からなる群より選ばれる植物の抽出物
の少なくとも1種であることを特徴とする請求項1また
は2記載の活性酸素消去剤。3. The plant extract comprises ashitaba, asparagus linealis, asenyak, arnica, ginkgo, nettle, oolong tea, ages, sardines, hypericum,
Chamomile, kawara mugwort, licorice, goldfish, cranberry fruit, clara, ginger ginger, black tea, comfrey, soapless, hawthorn, linden, peony,
White birch, horsetail, western locust, western elderberry, western mouse, narwhal, sage, mallow, chinpi, centipede, tencha, tea, clove, eucalyptus, duckweed, ginkgo, nobara, hibiscus flower, hamamelis, Hikikoshi, grape leaf, grape Fruit, button, hop, horse chestnut, melissa, peach leaf,
The active oxygen scavenger according to claim 1 or 2, which is at least one kind of an extract of a plant selected from the group consisting of cornflower, yukinoshita, yuzu, mugwort, rosemary, and waremoko.
ミノ安息香酸オクチル、パラメトキシケイ皮酸オクチ
ル、ヒドロキシメトキシベンゾフェノン(オキシベンゾ
ン)、テトラヒドロキシベンゾフェノン、4-t-ブチル
-4-メトキシ-ジベンゾイルメタン、オクチルトリアゾ
ン及びその誘導体からなる群より選ばれる少なくとも1
種であることを特徴とする請求項1〜3のいずれか1項
記載の活性酸素消去剤。4. The oil-soluble ultraviolet absorber is octyl paradimethylaminobenzoate, octyl paramethoxycinnamate, hydroxymethoxybenzophenone (oxybenzone), tetrahydroxybenzophenone, 4-t-butyl.
At least 1 selected from the group consisting of 4-methoxy-dibenzoylmethane, octyltriazone and its derivatives
The active oxygen scavenger according to any one of claims 1 to 3, which is a seed.
酸素消去剤を含有する事を特徴とする老化防止用皮膚化
粧料。5. An anti-aging skin cosmetic containing the active oxygen scavenger according to any one of claims 1 to 4.
する植物エキスおよび水中に可溶化された油溶性紫外線
吸収剤を含むことを特徴とする、フラボノイド及び/又
はタンニンを含有する植物エキスの活性酸素消去能の安
定化方法。6. A plant extract containing flavonoids and / or tannins, which comprises a plant extract containing flavonoids and / or tannins and an oil-soluble ultraviolet absorber solubilized in water, and the ability to eliminate active oxygen in the plant extract containing flavonoids and / or tannins. Stabilization method.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001211889A JP2003026560A (en) | 2001-07-12 | 2001-07-12 | Activated oxygen-eliminating agent, skin cosmetic material for preventing aging, and method for stabilizing activated oxygen-eliminating activity |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001211889A JP2003026560A (en) | 2001-07-12 | 2001-07-12 | Activated oxygen-eliminating agent, skin cosmetic material for preventing aging, and method for stabilizing activated oxygen-eliminating activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2003026560A true JP2003026560A (en) | 2003-01-29 |
Family
ID=19047135
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001211889A Pending JP2003026560A (en) | 2001-07-12 | 2001-07-12 | Activated oxygen-eliminating agent, skin cosmetic material for preventing aging, and method for stabilizing activated oxygen-eliminating activity |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2003026560A (en) |
Cited By (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003171225A (en) * | 2001-11-30 | 2003-06-17 | Fancl Corp | Composition for promoting integrin α6β4 production |
| JP2003267822A (en) * | 2002-03-14 | 2003-09-25 | Noevir Co Ltd | Skin care preparation |
| JP2004231602A (en) * | 2003-01-31 | 2004-08-19 | Hideji Watanabe | Buccal composition containing galenical extract having antioxidation activity |
| JP2005060320A (en) * | 2003-08-14 | 2005-03-10 | Nippon Network:Kk | Skin acaricide and external preparation for skin containing the same acaricide |
| JP2005350399A (en) * | 2004-06-11 | 2005-12-22 | Ako Kasei Co Ltd | Skin care preparation for external use comprising inorganic salt exhibiting antioxidative activity |
| JP2007516185A (en) * | 2003-07-07 | 2007-06-21 | トレル、 ジャン ノエル | Use of antioxidants in dermatological and / or cosmetic compositions |
| JP2007204414A (en) * | 2006-02-01 | 2007-08-16 | Jukobi Kk | Cosmetic composition and cosmetic for improving acne |
| JP2007246410A (en) * | 2006-03-14 | 2007-09-27 | Mandom Corp | Sun burn cell formation inhibitor and dna damage repair promoter |
| JP2007277149A (en) * | 2006-04-06 | 2007-10-25 | Kao Corp | Involucrin expression promoter |
| JP2007291069A (en) * | 2006-03-31 | 2007-11-08 | Daiichi Sankyo Healthcare Co Ltd | Antioxidant and/or analgesic and anti-inflammatory agent |
| JP2007314462A (en) * | 2006-05-25 | 2007-12-06 | Nippon Tablet Kk | External preparation |
| JP2008530288A (en) * | 2005-02-09 | 2008-08-07 | エシロール アンテルナシオナル (コンパニー ジェネラレ ドプテイク) | Stabilized UV absorber |
| JP2008247783A (en) * | 2007-03-29 | 2008-10-16 | Naris Cosmetics Co Ltd | External preparation composition |
| JP2008290970A (en) * | 2007-05-24 | 2008-12-04 | Mandom Corp | Sunburn cell development inhibitor, and composition for sun care formulation containing the same |
| WO2010001926A1 (en) * | 2008-07-02 | 2010-01-07 | 株式会社資生堂 | Water-containing composition |
| JP2010013374A (en) * | 2008-07-02 | 2010-01-21 | Shiseido Co Ltd | Water-containing composition |
| JP2010013375A (en) * | 2008-07-02 | 2010-01-21 | Shiseido Co Ltd | Water-containing composition |
| US7754249B2 (en) | 2004-06-15 | 2010-07-13 | The Boots Company Plc | Haircare compositions and methods |
| JP2011021001A (en) * | 2009-06-01 | 2011-02-03 | Lvmh Recherche | Use of high polyphenol plant extract as antioxidant combined with moisturizer or humectant |
| JP2012171877A (en) * | 2011-02-18 | 2012-09-10 | Kose Corp | Antioxidant, agent for improving skin turgor or sagging, radical scavenger and elastase activity inhibitor |
| CN103027877A (en) * | 2012-12-14 | 2013-04-10 | 吴江市德佐日用化学品有限公司 | Plant hand sanitizer |
| CN103908558A (en) * | 2014-04-22 | 2014-07-09 | 福州永同惠生物医药科技有限公司 | Traditional Chinese medicine composition for treating acne and preparation method and application thereof |
| JP2017160186A (en) * | 2016-03-07 | 2017-09-14 | 御木本製薬株式会社 | Kallikrein associated peptidase production-promoting agent, lekti production-promoting agent, slpi production-promoting agent, cornification normalizing agent, and corneodesmosome degradation normalizing agent |
| WO2019003963A1 (en) | 2017-06-30 | 2019-01-03 | 株式会社 資生堂 | OXYGEN TRAPPER SINGULET |
| WO2019225728A1 (en) * | 2018-05-25 | 2019-11-28 | ポーラ化成工業株式会社 | Method for screening for components that improve condition of aged or hypoxic skin, and method for estimating oxygen level of subdermal tissue or fibrosis level of subdermal adipocytes as index of subdermal tissue viscoelasticity |
| JP2019207232A (en) * | 2018-05-25 | 2019-12-05 | ポーラ化成工業株式会社 | Screening method using, as index, expression level of lox gene in hypoxia condition, increase inhibitor of expression of lox gene, fibrosis inhibitor of subcutaneous fat cell, and improvement or preventive agent of sagging |
| JP2024517077A (en) * | 2021-04-07 | 2024-04-19 | ユニリーバー・アイピー・ホールディングス・ベスローテン・ヴェンノーツハップ | Cosmetic composition containing hinokitiol |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63145213A (en) * | 1986-12-08 | 1988-06-17 | Kanebo Ltd | Prevention of change of color of polyphenol |
| JPS649946A (en) * | 1987-07-01 | 1989-01-13 | Kanebo Ltd | Method for preventing discoloration of polyphenol |
| JPH07206665A (en) * | 1994-01-13 | 1995-08-08 | Lion Corp | Bath agent composition |
-
2001
- 2001-07-12 JP JP2001211889A patent/JP2003026560A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63145213A (en) * | 1986-12-08 | 1988-06-17 | Kanebo Ltd | Prevention of change of color of polyphenol |
| JPS649946A (en) * | 1987-07-01 | 1989-01-13 | Kanebo Ltd | Method for preventing discoloration of polyphenol |
| JPH07206665A (en) * | 1994-01-13 | 1995-08-08 | Lion Corp | Bath agent composition |
Non-Patent Citations (2)
| Title |
|---|
| 化粧品ハンドブック, JPN6008021690, 1 November 1996 (1996-11-01), pages 455 - 459, ISSN: 0001037193 * |
| 新化粧品学, vol. 第2版1刷, JPN6008021692, 18 January 2001 (2001-01-18), pages 160 - 162, ISSN: 0001037194 * |
Cited By (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003171225A (en) * | 2001-11-30 | 2003-06-17 | Fancl Corp | Composition for promoting integrin α6β4 production |
| JP2003267822A (en) * | 2002-03-14 | 2003-09-25 | Noevir Co Ltd | Skin care preparation |
| JP2004231602A (en) * | 2003-01-31 | 2004-08-19 | Hideji Watanabe | Buccal composition containing galenical extract having antioxidation activity |
| JP2007516185A (en) * | 2003-07-07 | 2007-06-21 | トレル、 ジャン ノエル | Use of antioxidants in dermatological and / or cosmetic compositions |
| JP2005060320A (en) * | 2003-08-14 | 2005-03-10 | Nippon Network:Kk | Skin acaricide and external preparation for skin containing the same acaricide |
| JP2005350399A (en) * | 2004-06-11 | 2005-12-22 | Ako Kasei Co Ltd | Skin care preparation for external use comprising inorganic salt exhibiting antioxidative activity |
| US7754249B2 (en) | 2004-06-15 | 2010-07-13 | The Boots Company Plc | Haircare compositions and methods |
| JP2008530288A (en) * | 2005-02-09 | 2008-08-07 | エシロール アンテルナシオナル (コンパニー ジェネラレ ドプテイク) | Stabilized UV absorber |
| JP2007204414A (en) * | 2006-02-01 | 2007-08-16 | Jukobi Kk | Cosmetic composition and cosmetic for improving acne |
| JP2007246410A (en) * | 2006-03-14 | 2007-09-27 | Mandom Corp | Sun burn cell formation inhibitor and dna damage repair promoter |
| JP2007291069A (en) * | 2006-03-31 | 2007-11-08 | Daiichi Sankyo Healthcare Co Ltd | Antioxidant and/or analgesic and anti-inflammatory agent |
| JP2007277149A (en) * | 2006-04-06 | 2007-10-25 | Kao Corp | Involucrin expression promoter |
| JP2007314462A (en) * | 2006-05-25 | 2007-12-06 | Nippon Tablet Kk | External preparation |
| JP2008247783A (en) * | 2007-03-29 | 2008-10-16 | Naris Cosmetics Co Ltd | External preparation composition |
| JP2008290970A (en) * | 2007-05-24 | 2008-12-04 | Mandom Corp | Sunburn cell development inhibitor, and composition for sun care formulation containing the same |
| WO2010001926A1 (en) * | 2008-07-02 | 2010-01-07 | 株式会社資生堂 | Water-containing composition |
| JP2010013374A (en) * | 2008-07-02 | 2010-01-21 | Shiseido Co Ltd | Water-containing composition |
| JP2010013375A (en) * | 2008-07-02 | 2010-01-21 | Shiseido Co Ltd | Water-containing composition |
| KR101746843B1 (en) * | 2009-06-01 | 2017-06-27 | 엘브이엠에이취 러쉐르쉐 | Use of a polyphenol-rich plant extract as antioxidant in combination with a hydrating or humectant agent |
| JP2011021001A (en) * | 2009-06-01 | 2011-02-03 | Lvmh Recherche | Use of high polyphenol plant extract as antioxidant combined with moisturizer or humectant |
| JP2012171877A (en) * | 2011-02-18 | 2012-09-10 | Kose Corp | Antioxidant, agent for improving skin turgor or sagging, radical scavenger and elastase activity inhibitor |
| CN103027877A (en) * | 2012-12-14 | 2013-04-10 | 吴江市德佐日用化学品有限公司 | Plant hand sanitizer |
| CN103908558A (en) * | 2014-04-22 | 2014-07-09 | 福州永同惠生物医药科技有限公司 | Traditional Chinese medicine composition for treating acne and preparation method and application thereof |
| JP2017160186A (en) * | 2016-03-07 | 2017-09-14 | 御木本製薬株式会社 | Kallikrein associated peptidase production-promoting agent, lekti production-promoting agent, slpi production-promoting agent, cornification normalizing agent, and corneodesmosome degradation normalizing agent |
| JP7021762B2 (en) | 2016-03-07 | 2022-02-17 | 御木本製薬株式会社 | Kallikrein-related peptidase production promoter, LEKTI production promoter, SLPI production promoter, keratinization normalizer, corneodesmosome degradation normalizer |
| WO2019003963A1 (en) | 2017-06-30 | 2019-01-03 | 株式会社 資生堂 | OXYGEN TRAPPER SINGULET |
| US11390808B2 (en) | 2017-06-30 | 2022-07-19 | Shiseido Company, Ltd. | Singlet oxygen scavenger |
| WO2019225728A1 (en) * | 2018-05-25 | 2019-11-28 | ポーラ化成工業株式会社 | Method for screening for components that improve condition of aged or hypoxic skin, and method for estimating oxygen level of subdermal tissue or fibrosis level of subdermal adipocytes as index of subdermal tissue viscoelasticity |
| JP2019207232A (en) * | 2018-05-25 | 2019-12-05 | ポーラ化成工業株式会社 | Screening method using, as index, expression level of lox gene in hypoxia condition, increase inhibitor of expression of lox gene, fibrosis inhibitor of subcutaneous fat cell, and improvement or preventive agent of sagging |
| JP7328793B2 (en) | 2018-05-25 | 2023-08-17 | ポーラ化成工業株式会社 | Screening method using the expression level of lox gene under hypoxic conditions as an index, inhibitor of increase in lox gene expression, inhibitor of subcutaneous adipocyte fibrosis, and agent for improving or preventing sagging |
| JP2024517077A (en) * | 2021-04-07 | 2024-04-19 | ユニリーバー・アイピー・ホールディングス・ベスローテン・ヴェンノーツハップ | Cosmetic composition containing hinokitiol |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003026560A (en) | Activated oxygen-eliminating agent, skin cosmetic material for preventing aging, and method for stabilizing activated oxygen-eliminating activity | |
| JP6081551B2 (en) | Composition comprising sorbitan monocaprylate and antibacterial active substance | |
| JP3532244B2 (en) | Mucopolysaccharide fragmentation inhibitor, active oxygen scavenger and cosmetic | |
| KR20090095992A (en) | Hair cosmetic composition containing black grain extract as an active ingredient | |
| WO2003002074A1 (en) | Emulsion compositions | |
| JP2001151633A (en) | Preparation for external use for skin | |
| JP2005187474A (en) | Improved scented cosmetic | |
| JP4831849B2 (en) | Active oxygen scavenger and its use | |
| WO2002076479A1 (en) | Composition for treating acne vulgaris and fabrication method | |
| JP5561912B2 (en) | Extract from sturgeon eggs | |
| JP2004352688A (en) | Preservative composition | |
| JP2002167307A (en) | Cosmetic | |
| JPH09291013A (en) | Skin cosmetic material | |
| JP3199283B2 (en) | Anti-inflammatory agent | |
| JP7187740B2 (en) | new use | |
| JP2780803B2 (en) | External preparation for skin | |
| JP2025171233A (en) | Topical skin preparation | |
| JP2011195539A (en) | Elastase activity inhibitor | |
| JP2696523B2 (en) | Anti-dandruff agent and hair cosmetic | |
| JP2786232B2 (en) | New skin external preparation | |
| CN110831570B (en) | New use | |
| JP2002145754A (en) | Skin cosmetic | |
| JPH107582A (en) | Skin lotion | |
| JP2780805B2 (en) | New skin external preparation composition | |
| JP4044988B2 (en) | Cosmetics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20040805 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20040806 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20060328 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20061020 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20080428 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080507 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080626 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20080722 |